COVID-19 Pandemic Accelerates Growth of Global Point of Care/Rapid Diagnostic Market.

 

The global Point of Care/Rapid Diagnostic Market is expected to witness significant growth in the coming years, according to VynZ Research. With the increasing prevalence of chronic diseases and the rising demand for quick and accurate diagnostic tests, the market is projected to reach USD 58.5 billion by 2030, growing at a CAGR of 12% from 2022 to 2030.

Point of care testing (POCT) is a medical diagnostic testing that is performed outside the laboratory and in close proximity to the patient. POCT devices provide results in a timely manner, allowing healthcare professionals to make informed decisions about patient care. The increasing adoption of POCT devices in both developed and developing countries is a key driver of market growth.

Rapid diagnostic tests (RDTs) are another segment of the Point of Care/Rapid Diagnostic Market that is experiencing significant growth. RDTs are used for the detection of infectious diseases such as malaria, tuberculosis, and HIV. These tests are cost-effective, easy to use, and provide results in a short amount of time. The increasing prevalence of infectious diseases and the need for quick and accurate diagnosis is driving the demand for RDTs.

North America is expected to dominate the global Point of Care/Rapid Diagnostic Market during the forecast period, owing to the presence of key market players, high healthcare expenditure, and increasing adoption of POCT devices in the region. The Asia-Pacific region is also expected to witness significant growth, due to the increasing prevalence of chronic diseases and the growing demand for quick and accurate diagnostic tests.

Key market players operating in the Point of Care/Rapid Diagnostic Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and BioMérieux SA, among others. These companies are focusing on product launches, partnerships, and collaborations to expand their market share and strengthen their position in the market.

In conclusion, the global Point of Care/Rapid Diagnostic Market is expected to witness significant growth in the coming years, driven by the increasing prevalence of chronic diseases, the growing demand for quick and accurate diagnostic tests, and the adoption of POCT devices and RDTs. North America is expected to dominate the market, while the Asia-Pacific region is expected to witness significant growth. Key market players are focusing on product launches, partnerships, and collaborations to strengthen their position in the market.

About Us

Global market research company, VynZ Research provides research, analytics, and consulting services for business plans. We provide specialized market research reports based on information that was predicted and estimated by industry professionals and experts. In addition to industry experts, the top-down and bottom-up approaches, data triangulation, and other techniques enable the market research leader to validate the data and deliver a major market study.

Contact Us:

Address: H.O - 9591 Fontainebleau Blvd. 617 Miami Florida 33172 U.S.A

Phone: +91 9960 288 381

Toll Free:1 888 253 3960

Email: marketing@vynzresearch.com

Website: www.vynzresearch.com